292 related articles for article (PubMed ID: 24248419)
1. Epigenetic regulation of microRNAs in gastric cancer.
Ma J; Hong L; Chen Z; Nie Y; Fan D
Dig Dis Sci; 2014 Apr; 59(4):716-23. PubMed ID: 24248419
[TBL] [Abstract][Full Text] [Related]
2. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC
Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261
[TBL] [Abstract][Full Text] [Related]
6. Cancer type-specific epigenetic changes: gastric cancer.
Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
Shen R; Pan S; Qi S; Lin X; Cheng S
Biochem Biophys Res Commun; 2010 Apr; 394(4):1047-52. PubMed ID: 20331975
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations in gastric carcinogenesis.
Choi IS; Wu TT
Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
[TBL] [Abstract][Full Text] [Related]
11. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
Pavicic W; Perkiö E; Kaur S; Peltomäki P
Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
[TBL] [Abstract][Full Text] [Related]
14. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
16. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells.
Saito Y; Suzuki H; Tsugawa H; Nakagawa I; Matsuzaki J; Kanai Y; Hibi T
Oncogene; 2009 Jul; 28(30):2738-44. PubMed ID: 19503096
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
Deng H; Guo Y; Song H; Xiao B; Sun W; Liu Z; Yu X; Xia T; Cui L; Guo J
Gene; 2013 Apr; 518(2):351-9. PubMed ID: 23333942
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation as a molecular biomarker in gastric cancer.
Tahara T; Arisawa T
Epigenomics; 2015; 7(3):475-86. PubMed ID: 26077432
[TBL] [Abstract][Full Text] [Related]
19. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics: an emerging player in gastric cancer.
Kang C; Song JJ; Lee J; Kim MY
World J Gastroenterol; 2014 Jun; 20(21):6433-47. PubMed ID: 24914365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
